38 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34844106 | Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application. | 2022 Jan | 1 |
2 | 35496297 | Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells. | 2022 | 2 |
3 | 33524789 | The effects of metformin on autophagy. | 2021 May | 1 |
4 | 34163481 | Metformin, Macrophage Dysfunction and Atherosclerosis. | 2021 | 1 |
5 | 34895136 | Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way. | 2021 Dec 11 | 2 |
6 | 34911941 | Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. | 2021 Dec 15 | 1 |
7 | 32004509 | Metformin rescues Parkin protein expression and mitophagy in high glucose-challenged human renal epithelial cells by inhibiting NF-κB via PP2A activation. | 2020 Apr 1 | 2 |
8 | 32258978 | Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma. | 2020 Mar | 2 |
9 | 33014814 | Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway. | 2020 | 3 |
10 | 33184242 | High-glucose-induced apoptosis, ROS production and pro-inflammatory response in cardiomyocytes is attenuated by metformin treatment via PP2A activation. | 2020 | 2 |
11 | 30520054 | Metformin inhibits pro-inflammatory responses via targeting nuclear factor-κB in HaCaT cells. | 2019 Jan | 5 |
12 | 30628691 | Protective effects of metformin on lipopolysaccharide‑induced airway epithelial cell injury via NF‑κB signaling inhibition. | 2019 Mar | 4 |
13 | 30754072 | NF-κB as the mediator of metformin's effect on ageing and ageing-related diseases. | 2019 May | 1 |
14 | 30765814 | Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity. | 2019 Feb 14 | 2 |
15 | 30845774 | Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients. | 2019 Mar 6 | 1 |
16 | 31337349 | Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. | 2019 Jul 23 | 2 |
17 | 29396886 | Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma. | 2018 Apr | 4 |
18 | 29630425 | Suppressive effects of metformin on T-helper 1-related chemokines expression in the human monocytic leukemia cell line THP-1. | 2018 Nov | 3 |
19 | 29772687 | Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings. | 2018 May 16 | 2 |
20 | 30009823 | Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. | 2018 Sep 1 | 1 |
21 | 30097812 | Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments. | 2018 Dec | 1 |
22 | 30307719 | Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling. | 2018 Dec | 1 |
23 | 28159472 | Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. | 2017 Mar 1 | 1 |
24 | 29147073 | Metformin Suppressed CXCL8 Expression and Cell Migration in HEK293/TLR4 Cell Line. | 2017 | 2 |
25 | 27246734 | Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury. | 2016 Sep 2 | 1 |
26 | 27424158 | Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling. | 2016 Oct | 2 |
27 | 27706018 | Controls of Nuclear Factor-Kappa B Signaling Activity by 5'-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells. | 2016 Sep | 1 |
28 | 25772174 | Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. | 2015 | 2 |
29 | 26141671 | Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. | 2015 Nov | 4 |
30 | 26391700 | Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation. | 2015 Dec | 1 |
31 | 24243637 | Proinflammatory cytokine induction of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in human adipocytes is mediated by MEK, C/EBPβ, and NF-κB/RelA. | 2014 Jan | 1 |
32 | 25674239 | Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options. | 2014 | 1 |
33 | 23277563 | Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. | 2013 Jan 15 | 3 |
34 | 23510106 | Metformin: a case of divide and conquer. | 2013 Mar 11 | 1 |
35 | 23521863 | Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. | 2013 Jun | 5 |
36 | 20852028 | Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. | 2010 Dec | 1 |
37 | 16385087 | Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. | 2006 Mar | 3 |
38 | 15983226 | Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. | 2005 Jul | 1 |